CME Learning Center

Other Hematology

Continuing the Conversation: Elevating Equity in Caring for Patients With Hematologic Malignancies CME / ABIM MOC / CE How confident are you at recognizing and addressing inequities in the care of patients with hematologic malignancies?
Medscape Education Oncology, March 2023
Advances in Myelofibrosis: Updates on Emerging Treatments and Future Directions CME / ABIM MOC Did you know new treatments in development are being developed for myelofibrosis with the goal of changing the disease course?
March 2023
Building New Bridges to Transplant: A Focus on Emerging Bridging Strategies in Acute Myeloid Leukemia CME / ABIM MOC Hear updates from the winter meetings on novel approaches for getting older patients with acute myeloid leukemia (AML) to transplant.
Medscape Education Oncology, March 2023
Investigating Anemia and the Possibility of Pyruvate Kinase Deficiency: What Is' Your Next Step? CME / ABIM MOC Did you know that pyruvate kinase deficiency (PKD) is diagnosed using a combination of PK enzyme activity and PKLR molecular profiling?
Medscape Education Oncology, March 2023
BTK Inhibitors for CLL and MCL: What the Latest Data Mean for Our Patients CME / ABIM MOC Did you know noncovalent BTK inhibitor therapy is now an option for patients with pretreated MCL who fail a prior covalent BTK inhibitor therapy?
Medscape Education Oncology, March 2023
Tyrosine Kinase Inhibitors: Optimizing Treatment Options for Patients With Chronic Myeloid Leukemia CME / ABIM MOC How do you choose a tyrosine kinase inhibitor (TKI) for your patients with chronic myeloid leukemia (CML)? Join to hear an expert discussion on considerations and clinical data.
Medscape Education Oncology, March 2023
Resolving Complications With Complement: Updates on the Management of HSCT-TMA CME Are you up to date on emerging complement-blocking therapies for hematopoietic stem cell transplantation-associated thrombotic microangiopathy (HSCT-TMA)?
Medscape Education Oncology, March 2023
Case Challenges in Newly Diagnosed Multiple Myeloma CME / ABIM MOC How do you tailor treatment to the individual patient with newly diagnosed multiple myeloma (MM)?
Medscape Education Oncology, March 2023
New Treatment Strategies for Anemia in Chronic Kidney Disease: Where Do They Fit? CME / ABIM MOC What are the current treatment strategies for patients with chronic kidney disease (CKD) experiencing anemia?
Medscape Education Infectious Diseases, March 2023
Peer-to-Peer Clinical Connections: Sequencing Radioligand Therapies in Metastatic Castration-Resistant Prostate Cancer CME / ABIM MOC Did you know that radiopharmaceuticals for the treatment of metastatic castration-resistant prostate cancer (mCRPC) care have the potential to prolong survival and optimize the quality of life?
Medscape Education Oncology, March 2023
All for One in CKD Anemia Care CME / ABIM MOC Which specialists should be on your team in order to effectively manage anemia in patients with chronic kidney disease (CKD)?
Medscape Education Infectious Diseases, March 2023
Emerging Data From New Orleans on Classical Hematologic Disorders CME / ABIM MOC Are you up to date on recent data for clinical trials studying new therapies for classical hematologic disorders?
Medscape Education Oncology, March 2023
Chronic Leukemias CME / ABIM MOC / CE Do you know the latest approaches to treating chronic leukemias?
Medscape Education Oncology, March 2023
Are Gaps in Anemia and CKD Equal Across the Board? CME / ABIM MOC Is there a discrepancy in treatment of anemia in racial/ethnic minority patient populations with chronic kidney disease (CKD)?
Medscape Education Nephrology, March 2023
Emerging Approaches to Myelofibrosis Management CME / ABIM MOC What’s new in the treatment of myelofibrosis (MF)? Join to hear an overview of the latest data on new and emerging agents.
Medscape Education Oncology, March 2023
Leukemia, Myelodysplastic Syndromes, and Myeloproliferative Neoplasms CME / ABIM MOC / CE Expand your knowledge and skills by exploring the latest data on leukemia, myelodysplastic syndromes, and myeloproliferative neoplasms.
Medscape Education Oncology, February 2023
Higher-Risk Myelodysplastic Syndrome: A Team Approach to Optimizing Outcomes CME / ABIM MOC / CE Did you know there is a new way to categorize patients with myelodysplastic syndrome (MDS) that includes molecular information?
Medscape Education Oncology, February 2023
Managing Treatment-Naive Chronic Lymphocytic Leukemia With BTK Inhibitors: Test Your Skills CME / ABIM MOC / CE How would you treat these patients with chronic lymphocytic leukemia (CLL)?
Medscape Education Oncology, February 2023
Anemia of CKD: Consequences of Missing the Boat CME / ABIM MOC How does anemia in patients with chronic kidney disease (CKD) affect their health, quality of life, and economic situation?
Medscape Education Nephrology, February 2023
Myeloma, Lymphoma, and Benign Hematology CME / ABIM MOC / CE Expand your knowledge and skills by exploring the latest data in myeloma, lymphoma, and benign hematology.
Medscape Education Oncology, February 2023

Are Black and Minority Groups Underrepresented in Oncology Clinical Trials? CME / ABIM MOC / CE
Medscape Education Clinical Briefs, November 4, 2022
Dare to Compare: Do You Know the Latest on Immuno-Oncology in Advanced Non-Small Cell Lung Cancer? CME / ABIM MOC / CE
Medscape Education Clinical Briefs, October 14, 2022
Dare to Compare: How Well Do You Know CLL? CME / ABIM MOC / CE
Medscape Education Clinical Briefs, September 30, 2022
Who’s Taking Care of Older Cancer Survivors? CME / ABIM MOC / CE
Medscape Education Clinical Briefs, September 30, 2022
Can Motivational Interviewing via Text Affect Physical Activity in Pediatric Cancer Survivors? CME / ABIM MOC / CE
Medscape Education Clinical Briefs, July 29, 2022

CME Learning Center

Other Hematology

Latest Clinical Briefs

Further Reading